Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.

about

Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.

Item

http://www.wikidata.org/entity/Q55619003

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Long term impact of CTLA4 bloc ...... ses in patients with melanoma.

@en

Long term impact of CTLA4 bloc ...... ses in patients with melanoma.

@nl

type

Item

label

Long term impact of CTLA4 bloc ...... ses in patients with melanoma.

@en

Long term impact of CTLA4 bloc ...... ses in patients with melanoma.

@nl

prefLabel

Long term impact of CTLA4 bloc ...... ses in patients with melanoma.

@en

Long term impact of CTLA4 bloc ...... ses in patients with melanoma.

@nl

P1476

Long term impact of CTLA4 bloc ...... nses in patients with melanoma

@en

P2093

Alexis Nasr

http://www.w3.org/2001/XMLSchema#string

Huang Lin

http://www.w3.org/2001/XMLSchema#string

Janet Retseck

http://www.w3.org/2001/XMLSchema#string

Lisa H Butterfield

http://www.w3.org/2001/XMLSchema#string

Prateek Mendiratta

http://www.w3.org/2001/XMLSchema#string

Yan Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial

Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

Myeloid-derived suppressor cells as regulators of the immune system

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

CTLA-4 control over Foxp3+ regulatory T cell function

P2888

s12967-018-1563-y

P304

184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-018-1563-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ahmad Tarhini

P577

2018-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105309625

http://www.w3.org/2001/XMLSchema#string

P698

29973204

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

6033230

http://www.w3.org/2001/XMLSchema#string